H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 87 Citations 21,858 252 World Ranking 1258 National Ranking 755


What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Biochemistry

Richard L. Stevens mainly investigates Molecular biology, Mast cell, Biochemistry, Immunology and Proteases. His work deals with themes such as Interleukin 3, Cell culture, Gene, Recombinant DNA and Histamine, which intersect with Molecular biology. The various areas that Richard L. Stevens examines in his Mast cell study include Cellular differentiation, Protease, Connective tissue, Interleukin 33 and Degranulation.

His Biochemistry study frequently intersects with other fields, such as Immunoglobulin E. His work in the fields of Immunology, such as Inflammation, Eosinophil and Tryptase, overlaps with other areas such as Population. Richard L. Stevens interconnects Serine, Receptor, Serglycin, Cell biology and Granule in the investigation of issues within Proteases.

His most cited work include:

  • The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial (2415 citations)
  • Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. (448 citations)
  • Heparin is essential for the storage of specific granule proteases in mast cells (372 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Molecular biology, Mast cell, Biochemistry, Cell biology and Immunology. His studies examine the connections between Molecular biology and genetics, as well as such issues in Histamine, with regards to Prostaglandin D2 and Fibroblast. His Mast cell research is multidisciplinary, relying on both Proteases, Protease, Connective tissue, Interleukin 33 and Degranulation.

His study in Biochemistry focuses on Chondroitin sulfate, Glycosaminoglycan, Proteoglycan, Enzyme and Arylsulfatase A. His biological study spans a wide range of topics, including Sulfation and Heparin. As a part of the same scientific study, Richard L. Stevens usually deals with the Cell biology, concentrating on Immune system and frequently concerns with Natural killer cell.

He most often published in these fields:

  • Molecular biology (39.53%)
  • Mast cell (40.86%)
  • Biochemistry (41.20%)

What were the highlights of his more recent work (between 2003-2017)?

  • Immunology (18.94%)
  • Mast cell (40.86%)
  • Cell biology (21.93%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Immunology, Mast cell, Cell biology, Tryptase and Molecular biology. The concepts of his Immunology study are interwoven with issues in COPD and Lung. His Mast cell research is mostly focused on the topic Chymase.

Richard L. Stevens has included themes like Interleukin 33, Innate immune system, Biochemistry and Cytokine in his Cell biology study. The study incorporates disciplines such as Serine protease, Colitis, Proteases, Proteoglycan and Matrix metalloproteinase in addition to Tryptase. The Molecular biology study combines topics in areas such as Protease, Guanine nucleotide exchange factor, Signal transduction, Serglycin and Gene.

Between 2003 and 2017, his most popular works were:

  • Natural history of GATA1 mutations in Down syndrome (205 citations)
  • The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. (158 citations)
  • A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis (146 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • DNA

The scientist’s investigation covers issues in Immunology, Tryptase, Mast cell, Inflammation and Proteases. His Tryptase study integrates concerns from other disciplines, such as Serine protease, Colitis, Pathogenesis, Lung and Proinflammatory cytokine. His Mast cell research includes themes of Molecular biology, Elastase, Protease and Cell biology.

Richard L. Stevens interconnects Gene and TMPRSS6 in the investigation of issues within Molecular biology. He combines subjects such as Biochemistry and Cytokine with his study of Cell biology. His Proteases study deals with TRANSMEMBRANE TRYPTASE intersecting with Immunoglobulin E, Cathepsin G, Serglycin, Granzyme B and Proteoglycan.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

David Grimwade;Helen Walker;Fiona Oliver;Keith Wheatley.
Blood (1998)

3156 Citations

Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

M E Rothenberg;W F Owen;D S Silberstein;J Woods.
Journal of Clinical Investigation (1988)

537 Citations

Heparin is essential for the storage of specific granule proteases in mast cells

Donald E. Humphries;Guang W. Wong;Daniel S. Friend;Michael F. Gurish.
Nature (1999)

488 Citations

Recent advances in the cellular and molecular biology of mast cells

Richard L. Stevens;K. Frank Austen.
Immunology Today (1989)

456 Citations

Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.

E Razin;J N Ihle;D Seldin;J M Mencia-Huerta.
Journal of Immunology (1984)

443 Citations

Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.

W F Owen;M E Rothenberg;D S Silberstein;J C Gasson.
Journal of Experimental Medicine (1987)

423 Citations

IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity.

M E Rothenberg;J Petersen;R L Stevens;D S Silberstein.
Journal of Immunology (1989)

386 Citations

Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells.

F Levi-Schaffer;K F Austen;P M Gravallese;R L Stevens.
Proceedings of the National Academy of Sciences of the United States of America (1986)

365 Citations

Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate.

E Razin;R L Stevens;F Akiyama;K Schmid.
Journal of Biological Chemistry (1982)

349 Citations

Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes

Ryoji Matsumoto;Hiroyuki Matsumoto;Masako Seki;Mitsumi Hata.
Journal of Biological Chemistry (1998)

320 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Richard L. Stevens

Gunnar Pejler

Gunnar Pejler

Uppsala University

Publications: 115

Philip M. Hansbro

Philip M. Hansbro

University of Technology Sydney

Publications: 108

Stephen J. Galli

Stephen J. Galli

Stanford University

Publications: 92

Mitsuomi Hirashima

Mitsuomi Hirashima

Kagawa University

Publications: 87

Francesca Levi-Schaffer

Francesca Levi-Schaffer

Hebrew University of Jerusalem

Publications: 62

K. Frank Austen

K. Frank Austen

Brigham and Women's Hospital

Publications: 60

Alan Kenneth Burnett

Alan Kenneth Burnett

Cardiff University

Publications: 58

George H. Caughey

George H. Caughey

University of California, San Francisco

Publications: 57

Lawrence B. Schwartz

Lawrence B. Schwartz

Virginia Commonwealth University

Publications: 56

Yukihiko Kitamura

Yukihiko Kitamura

Osaka University

Publications: 55

Michael F. Gurish

Michael F. Gurish

Brigham and Women's Hospital

Publications: 53

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 47

Torsten Haferlach

Torsten Haferlach

MLL Munich Leukemia Laboratory

Publications: 46

Joshua A. Boyce

Joshua A. Boyce

Brigham and Women's Hospital

Publications: 46

Wolfgang Kern

Wolfgang Kern

Munich Leukemia Laboratory (Germany)

Publications: 44

Susanne Schnittger

Susanne Schnittger

Ludwig-Maximilians-Universität München

Publications: 43

Something went wrong. Please try again later.